Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-15 4:06 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 2,884,680 5.800% | 561,390 (+24.16%) | View |
| 2024-11-14 5:48 pm Sale | 13G | SCPHARMACEUTICALS INC SCPH | Lundbeckfond Invest A/S | 2,863,987 5.700% | -319,999 (-10.05%) | View |
| 2024-11-14 3:58 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | LYTTON LAURENCE W | 2,944,932 5.900% | 1,119,698 (+61.35%) | View |
| 2024-10-30 4:05 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 2,323,290 4.600% | 22,400 (+0.97%) | View |
| 2024-08-15 4:47 pm Purchase | 13D | SCPHARMACEUTICALS INC SCPH | ORBIMED ADVISORS LLC | 6,059,528 12.100% | 500,000 (+8.99%) | View |
| 2024-07-02 4:06 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 2,300,890 6.400% | 404,301 (+21.32%) | View |
| 2024-05-20 4:05 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 1,896,589 5.300% | 1,896,589 (New Position) | View |
| 2024-04-29 2:34 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | LYTTON LAURENCE W | 1,825,234 5.100% | 1,825,234 (New Position) | View |
| 2024-04-05 12:21 pm Sale | 13G | SCPHARMACEUTICALS INC SCPH | BlackRock Inc. BLK | 1,801,610 4.990% | -61,829 (-3.32%) | View |
| 2024-02-14 4:25 pm Sale | 13G | SCPHARMACEUTICALS INC SCPH | 5AM Ventures IV L.P. | 1,200,647 3.300% | -1,534,205 (-56.10%) | View |
| 2024-02-14 2:56 pm Sale | 13G | SCPHARMACEUTICALS INC SCPH | ARMISTICE CAPITAL LLC | 0 0.000% | -2,148,000 (Position Closed) | View |
| 2024-02-12 06:06 am Purchase | 13G | SCPHARMACEUTICALS INC SCPH | Rubric Capital Management LP | 3,500,000 9.760% | 3,500,000 (New Position) | View |
| 2024-02-07 6:55 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | HIRSCHMAN ORIN | 3,106,795 8.700% | 556,561 (+21.82%) | View |
| 2024-02-02 3:57 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | BlackRock Inc. BLK | 1,863,439 5.200% | 1,863,439 (New Position) | View |
| 2024-02-02 12:35 pm Sale | 13G | SCPHARMACEUTICALS INC SCPH | Cowen Financial Products LLC | 0 0.000% | -2,407,562 (Position Closed) | View |
| 2024-01-12 4:16 pm Sale | 13G | SCPHARMACEUTICALS INC SCPH | MILLENNIUM MANAGEMENT LLC | 356,873 1.000% | -1,365,966 (-79.29%) | View |
| 2023-03-13 4:45 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | MILLENNIUM MANAGEMENT LLC | 1,722,839 5.100% | 1,722,839 (New Position) | View |
| 2023-02-27 10:06 am Purchase | 13G | SCPHARMACEUTICALS INC SCPH | Cowen Financial Products LLC | 2,407,562 7.070% | 2,407,562 (New Position) | View |
| 2023-02-15 06:39 am Unchanged | 13G | SCPHARMACEUTICALS INC SCPH | HIRSCHMAN ORIN | 2,550,234 7.500% | 0 (Unchanged) | View |
| 2023-02-14 4:04 pm Sale | 13G | SCPHARMACEUTICALS INC SCPH | 5AM Ventures IV L.P. | 2,734,852 8.000% | -1,096,622 (-28.62%) | View |